Home > Insider Trading > Filing (0001415889-24-001931)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638474	W. Jeffrey Albers	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-01-25	15,000	$1.87	191,050	No	4	M	Direct
Common Stock	Acquisiton	2024-01-25	10,000	$15.01	201,050	No	4	M	Direct
Common Stock	Disposition	2024-01-25	6,086	$81.16	194,964	No	4	S	Direct
Common Stock	Disposition	2024-01-25	10,890	$81.70	184,074	No	4	S	Direct
Common Stock	Disposition	2024-01-25	7,924	$82.76	176,150	No	4	S	Direct
Common Stock	Disposition	2024-01-25	100	$83.57	176,050	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-01-25	15,000	$0.00	15,000	$1.87
Common Stock	Stock Option (Right to Buy)	Disposition	2024-01-25	10,000	$0.00	10,000	$15.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,073		2024-07-30	No	4	M	Direct
2,496		2026-02-03	No	4	M	Direct

Footnotes

Effected pursuant to a trading plan adopted on May 26, 2023 in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.42 to $81.41 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4).
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $81.42 to $82.41 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.42 to $83.24 per share.
This option was granted on July 30, 2014 and is fully vested as of the date hereof.
This option was granted on February 3, 2016 and is fully vested as of the date hereof.